Nuria Saigi-Morgui (Núria Saigí-Morgui)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Acute Myocardial Infarction

Risk Assessment

Cross Sectional

Iron Deficiency

Top Venues

Clinical drug investigation

International journal of chronic obstructive pulmonary disease

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, David Martinez, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. International journal of chronic obstructive pulmonary disease 17 (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Joan Fortuny, Gero von Gersdorff, Régis Lassalle, Marie Linder, Jetty A Overbeek, Jonas Reinold, Gunnar Toft, Antje Timmer, Jochen Dress, Patrick Blin, Cécile Droz-Perroteau, Vera Ehrenstein, Carla Franzoni, Ron M C Herings, Bianca Kollhorst, Nicholas Moore, Ingvild Odsbu, Susanna Perez-Gutthann, Cristina Rebordosa, Katherine Rascher, Lawrence Rasouliyan, Kenneth J Rothman, Nuria Saigi-Morgui, Mathias Schaller, Elisabeth Smits, Michael Forstner, null null, Jacques Benichou, Andreas J Bircher, Edeltraut Garbe, David S Rampton, Lia Gutiérrez
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety 30 (10) (2021)